Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Daiichi Sankyo
Dow
US Department of Justice
Harvard Business School
Queensland Health
Express Scripts
Merck

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080706

« Back to Dashboard

NDA 080706 describes ALA-CORT, which is a drug marketed by Crown Labs and is included in two NDAs. It is available from three suppliers. Additional details are available on the ALA-CORT profile page.

The generic ingredient in ALA-CORT is hydrocortisone. There are sixty-four drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Summary for 080706
Tradename:ALA-CORT
Applicant:Crown Labs
Ingredient:hydrocortisone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 080706
Medical Subject Heading (MeSH) Categories for 080706
Suppliers and Packaging for NDA: 080706
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALA-CORT hydrocortisone CREAM;TOPICAL 080706 ANDA Crown Laboratories 0316-0126 N 0316-0126-03
ALA-CORT hydrocortisone CREAM;TOPICAL 080706 ANDA Crown Laboratories 0316-0126 N 0316-0126-01

Profile for product number 006

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Profile for product number 007

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength2.5%
Approval Date:Jan 5, 2016TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Covington
Accenture
Fish and Richardson
Deloitte
Fuji
US Army
Boehringer Ingelheim
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.